Table 2 Glycaemic control, lipid profile and renal function in both groups at baseline and at peak beta-blocker dose

7.7 ± 1.5

7.2 ± 1.2

0.02

7.0 ± 1.2

6.9 ± 1.3

0.92

4.1 ± 1.0

3.7 ± 1.1

0.07

3.1 ± 1.0

3.0 ± 1.2

0.67

2.2 ± 0.9

2.0 ± 0.9

0.08

1.5 ± 0.7

1.5 ± 1.0

0.83

1.9 ± 1.2

2.0 ± 1.5

0.66

1.6 ± 1.2

1.5 ± 0.9

0.52

53.6 ± 27.8

48.4 ± 27.4

0.01

60.4 ± 24.2

51.1 ± 26.9

< 0.01

0.7 ± 0.8

0.6 ± 0.72

0.6

0.9 ± 0.9

0.7 ± 1.0

1.00